Voyageur Pharmaceuticals shares successful environmental assessment for minerals subsidiary | News Direct

Voyageur Pharmaceuticals shares successful environmental assessment for minerals subsidiary

Voyageur Pharmaceuticals Ltd
News release by Voyageur Pharmaceuticals Ltd

facebook icon linkedin icon twitter icon pinterest icon email icon Toronto | June 08, 2023 01:32 PM Eastern Daylight Time

 

Voyageur Pharmaceuticals CEO Brent Willis joins Natalie Stoberman from the Proactive studios to discuss the successful completion of environmental and geotechnical field work assessment at its Frances Creek project site through its 100% owned subsidiary Voyageur Industrial Minerals.

Willis says this milestone allows Voyageur Pharmaceuticals to mine and quarry their own minerals for their drugs, resulting in reduced costs and competitive pricing. Willis adds this milestone signifies progress towards production and positions Voyageur's Industrial Minerals division to compete effectively in the market.

 

Contact Details

 

Proactive Investors

 

+1 604-688-8158

 

na-editorial@proactiveinvestors.com

project media

Tags

ProactiveInvestorsVoyageurPharmaceuticalsVerticalIntegrationIndustrialMineralsPharmaceuticalCompanyCompetitiveEdgeFrancesCreekProjectEnvironmentalAssessmentMiningQuarryingCostReductionProductionMilestoneQuarryPermitDrugsHealthcareSustainableSourcingSupplyChainMarketCompetitivenessBusinessNewsInnovationHealthTechPharmaIndustryIndustryUpdatesCompanyProgressCorporateStrategyFutureGrowthinvestinvestinginvestmentinvestorstockmarketstocksstockstockmarketnews